Otros idiomas SD BioSensor, Inc

Acciones

A137310

KR7137310009

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
10.540 ^KRW	+0,48 %		+4,46 %	-7,87 %

2023	SD Biosensor, Inc presenta los resultados del primer trimestre finalizado el 31 de marzo de 2023	CI
2023	SD Biosensor, Inc. Propone que se desaconseje el uso y la eliminación de determinadas pruebas COVID-19 Pilot para uso doméstico en los Estados Unidos debido a la contaminación microbiana en la solución líquida de eliminación	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Coronavirus disease 2019 (COVID-19) in special groups: A single-center experience in sickle cell disease patients in Saudi Arabia - Transgenic News room	29/02
MÄRKTE ASIEN/Freundlich - Schanghai schwächer	29/01
MÄRKTE ASIEN/Freundlich - Schanghai schwächer	29/01
MÄRKTE ASIEN/Freundlich - Evergrande brechen mit Liquidationsurteil ein	29/01
MÄRKTE ASIEN/Freundlich - Evergrande brechen mit Liquidationsurteil ein	29/01
SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc.	28/07/23
SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc.	27/07/23
Columbus Holding Company announced that it has received KRW 258.2251644 billion in funding from SD Biosensor, Inc	28/06/23
Columbus Holding Company announced that it expects to receive KRW 258.2251644 billion in funding from SD Biosensor, Inc	13/06/23
SD Biosensor, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
SD Biosensor, Inc. Proposes Discontuation of Use and Disposal of Specific Pilot COVID-19 At-Home Tests in the United States Due to Microbial Contamination in the Liquid Disposal Solution	04/05/23
SD Biosensor, SJL Partners Acquire Meridian Bioscience	31/01/23
SD BioSensor, Inc and SJL Partners completed the acquisition of Meridian Bioscience, Inc. from Impactive Capital LP, BlackRock, Inc., The Vanguard Group, Inc, Royce & Associates, LP and others.	31/01/23
DoubleVerify Holdings to Replace Meridian Bioscience in S&P SmallCap 600	26/01/23
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference 2023	13/01/23
Roche teams up with Pfizer on COVID-19 awareness campaign	14/12/22
Meridian Bioscience Says Closing Date of Pending Merger With SD Biosensor, Others Pushed Back to Jan. 31	12/12/22
Meridian Bioscience Fiscal Q4 Adjusted EPS, Revenue Decline	22/11/22
SD Biosensor Records 67% Jump in Q3 Profit; Shares Up 4%	04/11/22
Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use	12/10/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas SD BioSensor, Inc

Acciones

A137310

KR7137310009

Otros idiomas

Filtros